Patent details

EP3518960 Title: DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND

Basic Information

Publication number:
EP3518960
PCT Application Number:
EP2017074592
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177814258
PCT Publication Number:
WO2018060310
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
French Title of Invention:
SCHÉMA POSOLOGIQUE POUR COMPOSÉ PTH À LIBÉRATION CONTROLÉE
German Title of Invention:
DOSIERSCHEMA ZUR KONTROLLIERTEN FREISETZUNG EINER PTH-VERBINDUNG
SPC Number:

Dates

Filing date:
28/09/2017
Grant date:
19/07/2023
EP Publication Date:
07/08/2019
PCT Publication Date:
05/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/07/2023
EP B1 Publication Date:
19/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/07/2023
 
 

Name:
Ascendis Pharma Bone Diseases A/S
Address:
Tuborg Boulevard 12, 2900 Hellerup, Denmark (DK)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/07/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SPROGØE, Kennett
Address:
Denmark (DK)

2

Name:
HOLTEN-ANDERSEN, Lars
Address:
Denmark (DK)

3

Name:
KARPF, David Brian
Address:
United States (US)

Priority

1

Priority Number:
16191451
Priority Date:
29/09/2016
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
17155843
Priority Date:
13/02/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/29; A61K 9/00; A61K 47/34; A61P 5/18; A61P 7/00; A61P 7/04; A61P 17/14; A61P 19/02; A61P 19/08; A61P 19/10; A61P 29/00; A61K 9/16;

Publication

European Patent Bulletin

1

Issue number:
202329
Publication date:
19/07/2023
Description:
Grant (B1)

2

Issue number:
202334
Publication date:
23/08/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/09/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
PAVIS PAYMENTS GMBH
Filing date Document type Number of pages
21/07/2023 Power Of Attorney 1
24/07/2023 Outgoing Correspondence 1